Table of Content

1 Report Overview
1.1 Famciclovir Definition
1.2 Market by Type
1.2.1 Global Famciclovir Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 125 mg Tablets
1.2.3 250 mg Tablets
1.2.4 500 mg Tablets
1.3 Market Segment by Application
1.3.1 Global Famciclovir Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Cold Sores
1.3.3 Genital Herpes
1.3.4 Shingles
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Famciclovir Sales
2.1 Global Famciclovir Revenue Estimates and Forecasts 2018-2034
2.2 Global Famciclovir Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Famciclovir Revenue by Region
2.3.1 Global Famciclovir Revenue by Region (2018-2023)
2.3.2 Global Famciclovir Revenue by Region (2024-2034)
2.4 Global Famciclovir Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Famciclovir Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Famciclovir Sales Quantity by Region
2.6.1 Global Famciclovir Sales Quantity by Region (2018-2023)
2.6.2 Global Famciclovir Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Famciclovir Sales Quantity by Manufacturers
3.1.1 Global Famciclovir Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Famciclovir Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Famciclovir Sales in 2024
3.2 Global Famciclovir Revenue by Manufacturers
3.2.1 Global Famciclovir Revenue by Manufacturers (2018-2023)
3.2.2 Global Famciclovir Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Famciclovir Revenue in 2024
3.3 Global Famciclovir Sales Price by Manufacturers
3.4 Global Key Players of Famciclovir, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Famciclovir, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Famciclovir, Product Offered and Application
3.8 Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Famciclovir Sales Quantity by Type
4.1.1 Global Famciclovir Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Famciclovir Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Famciclovir Sales Quantity Market Share by Type (2018-2034)
4.2 Global Famciclovir Revenue by Type
4.2.1 Global Famciclovir Historical Revenue by Type (2018-2023)
4.2.2 Global Famciclovir Forecasted Revenue by Type (2024-2034)
4.2.3 Global Famciclovir Revenue Market Share by Type (2018-2034)
4.3 Global Famciclovir Price by Type
4.3.1 Global Famciclovir Price by Type (2018-2023)
4.3.2 Global Famciclovir Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Famciclovir Sales Quantity by Application
5.1.1 Global Famciclovir Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Famciclovir Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Famciclovir Sales Quantity Market Share by Application (2018-2034)
5.2 Global Famciclovir Revenue by Application
5.2.1 Global Famciclovir Historical Revenue by Application (2018-2023)
5.2.2 Global Famciclovir Forecasted Revenue by Application (2024-2034)
5.2.3 Global Famciclovir Revenue Market Share by Application (2018-2034)
5.3 Global Famciclovir Price by Application
5.3.1 Global Famciclovir Price by Application (2018-2023)
5.3.2 Global Famciclovir Price Forecast by Application (2024-2034)
6 North America
6.1 North America Famciclovir Sales by Company
6.1.1 North America Famciclovir Revenue by Company (2018-2023)
6.1.2 North America Famciclovir Sales Quantity by Company (2018-2023)
6.2 North America Famciclovir Market Size by Type
6.2.1 North America Famciclovir Sales Quantity by Type (2018-2034)
6.2.2 North America Famciclovir Revenue by Type (2018-2034)
6.3 North America Famciclovir Market Size by Application
6.3.1 North America Famciclovir Sales Quantity by Application (2018-2034)
6.3.2 North America Famciclovir Revenue by Application (2018-2034)
6.4 North America Famciclovir Market Size by Country
6.4.1 North America Famciclovir Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Famciclovir Revenue by Country (2018-2034)
6.4.3 North America Famciclovir Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Famciclovir Sales by Company
7.1.1 Europe Famciclovir Sales Quantity by Company (2018-2023)
7.1.2 Europe Famciclovir Revenue by Company (2018-2023)
7.2 Europe Famciclovir Market Size by Type
7.2.1 Europe Famciclovir Sales Quantity by Type (2018-2034)
7.2.2 Europe Famciclovir Revenue by Type (2018-2034)
7.3 Europe Famciclovir Market Size by Application
7.3.1 Europe Famciclovir Sales Quantity by Application (2018-2034)
7.3.2 Europe Famciclovir Revenue by Application (2018-2034)
7.4 Europe Famciclovir Market Size by Country
7.4.1 Europe Famciclovir Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Famciclovir Revenue by Country (2018-2034)
7.4.3 Europe Famciclovir Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Famciclovir Sales by Company
8.1.1 China Famciclovir Sales Quantity by Company (2018-2023)
8.1.2 China Famciclovir Revenue by Company (2018-2023)
8.2 China Famciclovir Market Size by Type
8.2.1 China Famciclovir Sales Quantity by Type (2018-2034)
8.2.2 China Famciclovir Revenue by Type (2018-2034)
8.3 China Famciclovir Market Size by Application
8.3.1 China Famciclovir Sales Quantity by Application (2018-2034)
8.3.2 China Famciclovir Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Famciclovir Sales by Company
9.1.1 APAC Famciclovir Sales Quantity by Company (2018-2023)
9.1.2 APAC Famciclovir Revenue by Company (2018-2023)
9.2 APAC Famciclovir Market Size by Type
9.2.1 APAC Famciclovir Sales Quantity by Type (2018-2034)
9.2.2 APAC Famciclovir Revenue by Type (2018-2034)
9.3 APAC Famciclovir Market Size by Application
9.3.1 APAC Famciclovir Sales Quantity by Application (2018-2034)
9.3.2 APAC Famciclovir Revenue by Application (2018-2034)
9.4 APAC Famciclovir Market Size by Region
9.4.1 APAC Famciclovir Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Famciclovir Revenue by Region (2018-2034)
9.4.3 APAC Famciclovir Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Famciclovir Sales by Company
10.1.1 Middle East, Africa and Latin America Famciclovir Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Famciclovir Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Famciclovir Market Size by Type
10.2.1 Middle East, Africa and Latin America Famciclovir Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Famciclovir Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Famciclovir Market Size by Application
10.3.1 Middle East, Africa and Latin America Famciclovir Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Famciclovir Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Famciclovir Market Size by Country
10.4.1 Middle East, Africa and Latin America Famciclovir Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Famciclovir Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Famciclovir Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis Famciclovir Products and Services
11.1.5 Novartis Famciclovir SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Overview
11.2.3 Mylan Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Mylan Famciclovir Products and Services
11.2.5 Mylan Famciclovir SWOT Analysis
11.2.6 Mylan Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Teva Famciclovir Products and Services
11.3.5 Teva Famciclovir SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Overview
11.4.3 Cipla Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Cipla Famciclovir Products and Services
11.4.5 Cipla Famciclovir SWOT Analysis
11.4.6 Cipla Recent Developments
11.5 Hikma
11.5.1 Hikma Company Information
11.5.2 Hikma Overview
11.5.3 Hikma Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Hikma Famciclovir Products and Services
11.5.5 Hikma Famciclovir SWOT Analysis
11.5.6 Hikma Recent Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Overview
11.6.3 Apotex Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Apotex Famciclovir Products and Services
11.6.5 Apotex Famciclovir SWOT Analysis
11.6.6 Apotex Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Aurobindo Pharma Famciclovir Products and Services
11.7.5 Aurobindo Pharma Famciclovir SWOT Analysis
11.7.6 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Macleods Pharmaceuticals Famciclovir Products and Services
11.8.5 Macleods Pharmaceuticals Famciclovir SWOT Analysis
11.8.6 Macleods Pharmaceuticals Recent Developments
11.9 Beijing Jialin Pharmaceutical
11.9.1 Beijing Jialin Pharmaceutical Company Information
11.9.2 Beijing Jialin Pharmaceutical Overview
11.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Beijing Jialin Pharmaceutical Famciclovir Products and Services
11.9.5 Beijing Jialin Pharmaceutical Famciclovir SWOT Analysis
11.9.6 Beijing Jialin Pharmaceutical Recent Developments
11.10 HETERO
11.10.1 HETERO Company Information
11.10.2 HETERO Overview
11.10.3 HETERO Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 HETERO Famciclovir Products and Services
11.10.5 HETERO Famciclovir SWOT Analysis
11.10.6 HETERO Recent Developments
11.11 Hainan choitec Pharmaceuticals
11.11.1 Hainan choitec Pharmaceuticals Company Information
11.11.2 Hainan choitec Pharmaceuticals Overview
11.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Hainan choitec Pharmaceuticals Famciclovir Products and Services
11.11.5 Hainan choitec Pharmaceuticals Recent Developments
11.12 Shandong Luoxin Pharmaceutical Group
11.12.1 Shandong Luoxin Pharmaceutical Group Company Information
11.12.2 Shandong Luoxin Pharmaceutical Group Overview
11.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Products and Services
11.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments
11.13 Chengdu Diao Pharmaceutical Group
11.13.1 Chengdu Diao Pharmaceutical Group Company Information
11.13.2 Chengdu Diao Pharmaceutical Group Overview
11.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Products and Services
11.13.5 Chengdu Diao Pharmaceutical Group Recent Developments
11.14 HISUN
11.14.1 HISUN Company Information
11.14.2 HISUN Overview
11.14.3 HISUN Famciclovir Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 HISUN Famciclovir Products and Services
11.14.5 HISUN Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Famciclovir Value Chain Analysis
12.2 Famciclovir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Famciclovir Production Mode & Process
12.4 Famciclovir Sales and Marketing
12.4.1 Famciclovir Sales Channels
12.4.2 Famciclovir Distributors
12.5 Famciclovir Customers
13 Market Dynamics
13.1 Famciclovir Industry Trends
13.2 Famciclovir Market Drivers
13.3 Famciclovir Market Challenges
13.4 Famciclovir Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Famciclovir Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 125 mg Tablets
Table 3. Major Manufacturers of 250 mg Tablets
Table 4. Major Manufacturers of 500 mg Tablets
Table 5. Global Famciclovir Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Famciclovir Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Famciclovir Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Famciclovir Revenue Market Share by Region (2018-2023)
Table 9. Global Famciclovir Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Famciclovir Revenue Market Share by Region (2024-2034)
Table 11. Global Famciclovir Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Famciclovir Sales by Region (2018-2023) & (K Units)
Table 13. Global Famciclovir Sales Market Share by Region (2018-2023)
Table 14. Global Famciclovir Sales by Region (2024-2034) & (K Units)
Table 15. Global Famciclovir Sales Market Share by Region (2024-2034)
Table 16. Global Famciclovir Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Famciclovir Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Famciclovir Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Famciclovir Revenue Share by Manufacturers (2018-2023)
Table 20. Global Famciclovir Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of Famciclovir, Industry Ranking, 2021 VS 2024
Table 22. Global Famciclovir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Famciclovir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Famciclovir as of 2024)
Table 24. Global Key Manufacturers of Famciclovir, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Famciclovir, Product Offered and Application
Table 26. Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Famciclovir Sales Quantity Share by Type (2018-2023)
Table 31. Global Famciclovir Sales Quantity Share by Type (2024-2034)
Table 32. Global Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Famciclovir Revenue Share by Type (2018-2023)
Table 35. Global Famciclovir Revenue Share by Type (2024-2034)
Table 36. Famciclovir Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Famciclovir Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Famciclovir Sales Quantity Share by Application (2018-2023)
Table 41. Global Famciclovir Sales Quantity Share by Application (2024-2034)
Table 42. Global Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Famciclovir Revenue Share by Application (2018-2023)
Table 45. Global Famciclovir Revenue Share by Application (2024-2034)
Table 46. Famciclovir Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Famciclovir Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Famciclovir Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Famciclovir Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Famciclovir Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Famciclovir Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Famciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Famciclovir Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Famciclovir Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Famciclovir Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Famciclovir Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Famciclovir Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Famciclovir Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Famciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Famciclovir Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Famciclovir Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Famciclovir Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Famciclovir Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Famciclovir Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Famciclovir Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Famciclovir Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Famciclovir Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Famciclovir Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Famciclovir Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Famciclovir Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Famciclovir Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Famciclovir Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Famciclovir Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Famciclovir Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Famciclovir Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Famciclovir Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Famciclovir Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Famciclovir Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Famciclovir Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Famciclovir Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Famciclovir Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Famciclovir Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Famciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Famciclovir Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Famciclovir Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Novartis Company Information
Table 119. Novartis Description and Overview
Table 120. Novartis Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Novartis Famciclovir Product and Services
Table 122. Novartis Famciclovir SWOT Analysis
Table 123. Novartis Recent Developments
Table 124. Mylan Company Information
Table 125. Mylan Description and Overview
Table 126. Mylan Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. Mylan Famciclovir Product and Services
Table 128. Mylan Famciclovir SWOT Analysis
Table 129. Mylan Recent Developments
Table 130. Teva Company Information
Table 131. Teva Description and Overview
Table 132. Teva Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Teva Famciclovir Product and Services
Table 134. Teva Famciclovir SWOT Analysis
Table 135. Teva Recent Developments
Table 136. Cipla Company Information
Table 137. Cipla Description and Overview
Table 138. Cipla Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Cipla Famciclovir Product and Services
Table 140. Cipla Famciclovir SWOT Analysis
Table 141. Cipla Recent Developments
Table 142. Hikma Company Information
Table 143. Hikma Description and Overview
Table 144. Hikma Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Hikma Famciclovir Product and Services
Table 146. Hikma Famciclovir SWOT Analysis
Table 147. Hikma Recent Developments
Table 148. Apotex Company Information
Table 149. Apotex Description and Overview
Table 150. Apotex Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Apotex Famciclovir Product and Services
Table 152. Apotex Famciclovir SWOT Analysis
Table 153. Apotex Recent Developments
Table 154. Aurobindo Pharma Company Information
Table 155. Aurobindo Pharma Description and Overview
Table 156. Aurobindo Pharma Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Aurobindo Pharma Famciclovir Product and Services
Table 158. Aurobindo Pharma Famciclovir SWOT Analysis
Table 159. Aurobindo Pharma Recent Developments
Table 160. Macleods Pharmaceuticals Company Information
Table 161. Macleods Pharmaceuticals Description and Overview
Table 162. Macleods Pharmaceuticals Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 163. Macleods Pharmaceuticals Famciclovir Product and Services
Table 164. Macleods Pharmaceuticals Famciclovir SWOT Analysis
Table 165. Macleods Pharmaceuticals Recent Developments
Table 166. Beijing Jialin Pharmaceutical Company Information
Table 167. Beijing Jialin Pharmaceutical Description and Overview
Table 168. Beijing Jialin Pharmaceutical Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 169. Beijing Jialin Pharmaceutical Famciclovir Product and Services
Table 170. Beijing Jialin Pharmaceutical Famciclovir SWOT Analysis
Table 171. Beijing Jialin Pharmaceutical Recent Developments
Table 172. HETERO Company Information
Table 173. HETERO Description and Overview
Table 174. HETERO Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 175. HETERO Famciclovir Product and Services
Table 176. HETERO Famciclovir SWOT Analysis
Table 177. HETERO Recent Developments
Table 178. Hainan choitec Pharmaceuticals Company Information
Table 179. Hainan choitec Pharmaceuticals Description and Overview
Table 180. Hainan choitec Pharmaceuticals Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 181. Hainan choitec Pharmaceuticals Famciclovir Product and Services
Table 182. Hainan choitec Pharmaceuticals Recent Developments
Table 183. Shandong Luoxin Pharmaceutical Group Company Information
Table 184. Shandong Luoxin Pharmaceutical Group Description and Overview
Table 185. Shandong Luoxin Pharmaceutical Group Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 186. Shandong Luoxin Pharmaceutical Group Famciclovir Product and Services
Table 187. Shandong Luoxin Pharmaceutical Group Recent Developments
Table 188. Chengdu Diao Pharmaceutical Group Company Information
Table 189. Chengdu Diao Pharmaceutical Group Description and Overview
Table 190. Chengdu Diao Pharmaceutical Group Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 191. Chengdu Diao Pharmaceutical Group Famciclovir Product and Services
Table 192. Chengdu Diao Pharmaceutical Group Recent Developments
Table 193. HISUN Company Information
Table 194. HISUN Description and Overview
Table 195. HISUN Famciclovir Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 196. HISUN Famciclovir Product and Services
Table 197. HISUN Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Famciclovir Distributors List
Table 201. Famciclovir Customers List
Table 202. Famciclovir Market Trends
Table 203. Famciclovir Market Drivers
Table 204. Famciclovir Market Challenges
Table 205. Famciclovir Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Famciclovir Product Picture
Figure 2. Global Famciclovir Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Famciclovir Market Share by Type in 2024 & 2034
Figure 4. 125 mg Tablets Product Picture
Figure 5. 250 mg Tablets Product Picture
Figure 6. 500 mg Tablets Product Picture
Figure 7. Global Famciclovir Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Famciclovir Market Share by Application in 2024 & 2034
Figure 9. Cold Sores
Figure 10. Genital Herpes
Figure 11. Shingles
Figure 12. Famciclovir Report Years Considered
Figure 13. Global Famciclovir Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Famciclovir Revenue 2018-2034 (US$ Million)
Figure 15. Global Famciclovir Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Famciclovir Sales Quantity 2018-2034 (K Units)
Figure 17. Global Famciclovir Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Famciclovir Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Famciclovir Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Famciclovir Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Famciclovir Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Famciclovir Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Famciclovir Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Famciclovir Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Famciclovir Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Famciclovir Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Famciclovir Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Famciclovir Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Famciclovir Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Famciclovir Revenue in 2024
Figure 31. Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Famciclovir Revenue Market Share by Type (2018-2034)
Figure 34. Global Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Famciclovir Revenue Market Share by Application (2018-2034)
Figure 36. North America Famciclovir Revenue Market Share by Company in 2024
Figure 37. North America Famciclovir Sales Quantity Market Share by Company in 2024
Figure 38. North America Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Famciclovir Revenue Market Share by Type (2018-2034)
Figure 40. North America Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Famciclovir Revenue Market Share by Application (2018-2034)
Figure 42. North America Famciclovir Revenue Share by Country (2018-2034)
Figure 43. North America Famciclovir Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Famciclovir Sales Quantity Market Share by Company in 2024
Figure 47. Europe Famciclovir Revenue Market Share by Company in 2024
Figure 48. Europe Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Famciclovir Revenue Market Share by Type (2018-2034)
Figure 50. Europe Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Famciclovir Revenue Market Share by Application (2018-2034)
Figure 52. Europe Famciclovir Revenue Share by Country (2018-2034)
Figure 53. Europe Famciclovir Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 55. France Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 59. China Famciclovir Sales Quantity Market Share by Company in 2024
Figure 60. China Famciclovir Revenue Market Share by Company in 2024
Figure 61. China Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Famciclovir Revenue Market Share by Type (2018-2034)
Figure 63. China Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Famciclovir Revenue Market Share by Application (2018-2034)
Figure 65. APAC Famciclovir Sales Quantity Market Share by Company in 2024
Figure 66. APAC Famciclovir Revenue Market Share by Company in 2024
Figure 67. APAC Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Famciclovir Revenue Market Share by Type (2018-2034)
Figure 69. APAC Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Famciclovir Revenue Market Share by Application (2018-2034)
Figure 71. APAC Famciclovir Revenue Share by Region (2018-2034)
Figure 72. APAC Famciclovir Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 77. India Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Famciclovir Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Famciclovir Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Famciclovir Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Famciclovir Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Famciclovir Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Famciclovir Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Famciclovir Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Famciclovir Revenue Share by Country (2018-2034)
Figure 86. Brazil Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Famciclovir Revenue (2018-2034) & (US$ Million)
Figure 91. Famciclovir Value Chain
Figure 92. Famciclovir Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed